Skip to main content
FinSpry Logo
FinSpry
GRFS logo
GRFS
(NASDAQ)
Grifols, S.A.
$7.18-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

Grifols (GRFS) Stock Price & Financial Analysis

Grifols Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$7.16 - $7.40
52-Week High$11.14
52-Week Low$7.16
Open$7.38
Volume656.35K
Average Volume (3M)618.91K
Market Cap4.89B
Shares Outstanding680.58M
P/E Ratio (TTM)10.32
Forward P/E4.12
Price to Sales (P/S)0.58
Price to Book (P/B)0.79
EV/EBITDA8.19
Revenue (TTM)8.49B
Net Income (TTM)473.45M
Free Cash Flow (TTM)802.62M
EPS (TTM)$0.87
Profit Margin5.58%
Operating Margin16.49%
Return on Equity (ROE)7.62%
Debt to Equity1.77
50-Day MA$7.92
200-Day MA$8.75
52-Week Change-14.22%
Annual Dividend$0.17
Dividend Yield2.41%
Payout Ratio19.87%
Last Dividend Ex-DateAug 20, 2026

Frequently Asked Questions About Grifols

What is the current stock price for GRFS?

As of the latest trading session, GRFS stock trades at $7.18. The 52-week range is $7.16–$11.14, with a day range of $7.16–$7.40.

What is the P/E ratio for GRFS?

Grifols's trailing P/E ratio is 10.3, meaning investors pay $10.3 for every $1 of annual earnings. The forward P/E is 4.1, reflecting analyst expectations for future earnings. Grifols operates in the Healthcare sector.

Does GRFS pay dividends?

Yes, Grifols pays a 2.41% annual dividend yield ($0.17 per share). The payout ratio is 19.9%. The last ex-dividend date was 2026-08-20.

What do analysts recommend for GRFS?

Analyst ratings and recommendations for GRFS are displayed in the Analyst Consensus section, including buy/hold/sell distribution and 12-month price targets.

What is the market cap of GRFS?

Grifols's market capitalization is $4.89B, classifying it as a mid-cap company. Grifols operates in the Healthcare sector within the Drug Manufacturers - General industry.